ArticleBone reports2022

Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes - Data from a randomized, placebo-controlled study.

Matthias Rau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.